Frequently Asked Question
What Drugs Can an Oral Fluid Drug Test Detect?
HHS publishes the oral fluid drug panel used in federal workplace programs. In March 2026 HHS stated that it "publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs" and made no changes to the oral fluid panel (91 FR 12308). The oral fluid panel covers marijuana (delta-9-THC), cocaine and its metabolite benzoylecgonine, codeine and morphine, hydrocodone and hydromorphone, oxycodone and oxymorphone, 6-acetylmorphine, phencyclidine (PCP), fentanyl, amphetamine and methamphetamine, and MDMA and MDA.
Each analyte has an initial test cutoff and a confirmatory test cutoff, both in nanograms per milliliter. The DOT oral fluid cutoff numbers and a note on fentanyl are in the cut-off levels FAQ. The HHS oral fluid guidelines require a federal agency to test each specimen for marijuana and cocaine and allow testing for the other drugs in the panel (Section 3.1). On a case-by-case basis, a federal agency may also test for other Schedule I or II drugs after a reasonable suspicion or post-accident collection (Section 3.2). HHS has not yet authorized routine biomarker testing in oral fluid.
The panel is written for federal agencies. SAMHSA states: "The Mandatory Guidelines for Federal Workplace Drug Testing Programs do not cover non-federal employees." They address federal civilian employees and the federal agencies required by law to use them, such as DOT. DOT-regulated employers use the separate oral fluid list in 49 CFR 40.91. Because the Guidelines do not cover non-federal employees, this panel does not govern a non-federal employer's non-DOT oral fluid test.
Related FAQ: Can a Hair Test Be Used for DOT Drug Testing?
Related FAQ: Which DOT Agencies Allow Oral Fluid Testing?
References
We are not a law firm. The information on this website is for informational purposes only and may not be up to date. Always consult a licensed attorney for personalized legal advice.